Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study.

Oliver Zolk Timo Greiner Michael SchneiderMartin HeinzeVolker DahlingTabea RaminRenate GrohmannStefan BleichTristan ZindlerSermin TotoCatharina Meissner

Published in: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry (2021)

In clinical routine, age has a significant impact on selection and dosing of APDs. Information on optimising pharmacotherapy in older adults with schizophrenia from clinical trials is needed. Guidelines should be improved regarding APD therapy specifically for older adults.

Keyphrases

bipolar disorder
cross sectional
clinical trial
physical activity
clinical practice
smoking cessation
middle aged
stem cells
emergency department
randomized controlled trial
combination therapy
drug induced
social media